
Multidrug resistant organism predicts ulcer recurrence following surgical management of diabetic foot osteomyelitis
Author(s) -
Schmidt Brian M.,
Ye Wen,
Zhou Shiwei
Publication year - 2020
Publication title -
international wound journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 63
eISSN - 1742-481X
pISSN - 1742-4801
DOI - 10.1111/iwj.13439
Subject(s) - medicine , osteomyelitis , diabetic foot , diabetic foot ulcer , amputation , diabetes mellitus , cohort , foot (prosody) , surgery , univariate analysis , retrospective cohort study , cohort study , multivariate analysis , linguistics , philosophy , endocrinology
Diabetic foot ulcers commonly precede diabetic foot osteomyelitis (DFO) and once the latter occurs, surgical management is often performed. The presence of osteomyelitis is an independent risk factor for the development of re‐ulceration. We investigated the relationship between causative organisms in osteomyelitis and 1‐year diabetic foot outcomes (re‐ulceration, amputation, and death) following surgical management in an observational cohort of 223 patients. Univariate and multivariate analyses were performed for available demographic, clinical, and laboratory data. In addition, random forest plots were used to identify microbiologic predictors of 1‐year outcomes. Patients with osteomyelitis managed surgically were younger and exhibited more painful peripheral neuropathy than outpatients with diabetes alone (both P < .0001 ) . Osteomyelitis proximal margin cultures were diverse, at times polymicrobial, and included multidrug‐resistant organisms in 13.9% of the cohort. In patients who underwent surgery, 44.5% experienced a re‐ulceration on the same foot within 12 months of surgery. The presence of multidrug‐resistant organisms on proximal bone culture was found to be a significant predictor of diabetic foot ulcer recurrence in univariate modelling ( P < .001) and importance rankings. This is the first study to use prediction modelling to identify a relationship between multidrug‐resistant organisms and diabetic foot ulcer recurrence following DFO.